RSS

memorandum of understanding (MOU)

CURE Pharmaceuticals, developer of drug delivery technology and pharmaceutical cannabinoid molecules, has signed a memorandum of understanding (MOU), entering into a research collaboration with two Israeli companies. more

Jul 12, 2017 12:34 PM News